is semaglutide hard on the kidneys just got FDA-approved for kidney disease. This changes everything. January 2025. FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in type 2 diabetes with CKD. This Semaglutide: A Breakthrough for Chronic
Description
Endogenous GLP-1 has a short half-life (23 minutes) and is rapidly metabolised after its secretion via the enzyme dipeptidyl peptidase (DPP-4), while GLP-1RAs have a prolonged half-life of approximately 7 days [2, 3], resulting in some long-lasting effects
It's important to note that while nausea is common, not all patients experience this side effect
If you want a straightforward, cost-effective approach, Remedy Meds is the better choice
Semaglutide, 3 Month Supply Get a discount on your Compounded Semaglutide with our 3-month quarterly plan
